Select Medical renews CEO Mullin under new agreement

Select Medical ( (SEM) ) has issued an update.

On December 17, 2025, Select Medical Corporation entered into a new employment agreement with its Chief Executive Officer, Thomas P. Mullin, effective January 1, 2026, under which he will continue as CEO for an initial one-year term with automatic one-year renewals, receiving an annual base salary of $700,000 and being subject to non-competition and non-solicitation restrictions during employment and for two years after. The agreement also provides that if Mullin is terminated by Select without cause and not due to death or disability, he will receive severance equal to 12 months of base salary, and the company confirmed there are no related-party, family, or other arrangements requiring additional regulatory disclosure, signaling a straightforward, governance-compliant leadership continuity arrangement for stakeholders.

The most recent analyst rating on (SEM) stock is a Buy with a $16.50 price target. To see the full list of analyst forecasts on Select Medical stock, see the SEM Stock Forecast page.

Spark’s Take on SEM Stock

According to Spark, TipRanks’ AI Analyst, SEM is a Outperform.

Select Medical’s overall stock score is driven by strong earnings call results and positive technical indicators, despite financial performance concerns related to high leverage and declining cash flow. The company’s strategic expansion and fair valuation further support the score.

To see Spark’s full report on SEM stock, click here.

More about Select Medical

Select Medical Corporation, a wholly owned subsidiary of Select Medical Holdings Corporation, operates in the healthcare services industry, providing specialized medical care through its network of facilities and services in the United States.

Average Trading Volume: 1,196,689

Technical Sentiment Signal: Buy

Current Market Cap: $1.86B

For a thorough assessment of SEM stock, go to TipRanks’ Stock Analysis page.